Loss of heterozygosity on chromosome 10q23 and mutation of the phosphatase and tensin homolog deleted from chromosome 10 tumor suppressor gene in Korean hepatocellular carcinoma patients

Oncology Reports

Volumn 18, Issue 4, 2007, Pages 1007-1013

  Bae, Jei Jun ^a   Rho, Jin Woo ^a   Lee, Tae Jin ^b   Yun, Sung Su ^a   Kim, Hong Jin ^a   Choi, Joon Hyuk ^a   Jeong, Daewon ^a   Jang, Byeong Churl ^b   Lee, Tae Yoon ^a  

^a Yeungnam University College of Medicine   (South Korea)

^b Keimyung University School of Medicine   (South Korea)

Author keywords

10q23; Alteration; Hepatocellular carcinoma; Loss of heterozygosity; Mutation; Phosphatase and tensin homolog deleted from chromosome 10

Indexed keywords

ACTIN BINDING PROTEIN; MICROSATELLITE DNA; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PTEN PROTEIN, HUMAN; TENSINS; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CHROMOSOME 10; FEMALE; GENE DELETION; GENETICS; HETEROZYGOSITY LOSS; HUMAN; KOREA; LIVER CELL CARCINOMA; LIVER TUMOR; MALE; MICROSATELLITE INSTABILITY; MIDDLE AGED; MUTATION; POLYMERASE CHAIN REACTION; SINGLE STRAND CONFORMATION POLYMORPHISM; TUMOR SUPPRESSOR GENE;

ADULT; AGED; CARCINOMA, HEPATOCELLULAR; CHROMOSOMES, HUMAN, PAIR 10; FEMALE; GENE DELETION; GENES, TUMOR SUPPRESSOR; HUMANS; KOREA; LIVER NEOPLASMS; LOSS OF HETEROZYGOSITY; MALE; MICROFILAMENT PROTEINS; MICROSATELLITE INSTABILITY; MICROSATELLITE REPEATS; MIDDLE AGED; MUTATION; POLYMERASE CHAIN REACTION; POLYMORPHISM, SINGLE-STRANDED CONFORMATIONAL; PTEN PHOSPHOHYDROLASE;

EID: 38449101817     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.18.4.1007     Document Type: Article

References (42)

1. Cameron RG: Identification of the putative first cellular step of chemical hepatocarcinogenesis. Cancer Lett 47: 163-167, 1989.
2. Miyazaki M and Namba M: Atlas of human tumor cell lines. In: Hepatocellular carcinomas. Hay RJ, Park J-G and Gazdar A (eds). Academic Press Inc., San Diego, pp185-212, 1994.
3. Tang ZY: Hepatocellular carcinoma. J Gastroenterol Hepatol 15 (Suppl): G1-G7, 2000.
4. Wang YE, Wang HY and Wu MC: Identification and characterization of a novel human hepatocellular carcinoma-associated gene. Br J Cancer 85: 1162-1167, 2001.
5. Suh CI, Suh KA, Park SH, Chang HJ, Ko JW and Ahn DH: Annual report of the central cancer registry in Korea-1998. J Korean Cancer Assoc 32: 827-834, 2000.
6. Dragon YP, Sargent L, Xu Y-D, Xu Y-H and Pitot HC: The initiation-promotion-progression model of rat hepatocarcinogenesis. Proc Soc Exp Biol Med 202: 16-24, 1993. (Pubitemid 23015576)
7. Biden K, Young J, Buttenshaw R, Searle J, Cooksley G, Xu DB and Leggett B: Frequency of mutation and deletion of the tumor suppressor gene CDKN2A (MTS1/p16) in hepatocellular carcinoma from an Australian population. Hepatology 25: 593-597, 1997. (Pubitemid 27106439)
8. Bressac B, Kew M, Wand J and Ozturk M: Selective G to T mutations of p53 gene in hepatocellular carcinoma from southern Africa. Nature 350: 429-431, 1991. (Pubitemid 21912246)
9. Hui AM, Sakamoto M, Kanai Y, Ino Y, Gotoh M, Yokota J and Hirohashi S: Inactivation of p16INK4 in hepatocellular carcinoma. Hepatology 24: 575-579, 1996.
10. Kaino M: Alterations in the tumor suppressor genes p53, RB, p16/MTS1, and p15/MTS2 in human pancreatic cancer and hepatoma cell lines. J Gastroenterol 32: 40-46, 1997.
11. Kang MS, Lee HJ, Lee JH, Ku JL, Lee KP, Kelley MJ, Won YJ, Kim ST and Park JG: Mutation of p53 gene in hepatocellular carcinoma cell lines with HBX DNA. Int J Cancer 67: 898-902, 1996. (Pubitemid 26348822)
12. Kita R, Nishida N, Fukuda Y, Azechi H, Matsuoka Y, Komeda T, Sando T, Nakao K and Ishizaki K: Infrequent alterations of the p16INK4A gene in liver cancer. Int J Cancer 67: 176-180, 1996. (Pubitemid 26274145)
13. Lee TJ, Bae JJ, Lee JS, Lee SY, Kim HJ, Kim SK, Lee JY and Lee TY: p16-Rb abrogation of the pathway in Korean hepatocellular carcinomas. J Hepatogastroenterol 47: 1663-1668, 2000.
14. Liew CT, Li HM, Lo KW, Leow CK, Chan JY, Hin LY, Lau WY, Lai PB, Lim BK, Huang J, Leung WT, Wu S and Lee JC: High frequency of p16INK4A gene alterations in hepatocellular carcinoma. Oncogene 18: 789-795, 1999. (Pubitemid 29080337)
15. Li J, Yen C, Liaw D, Podsypanina K, Bose S, Wang SI, Puc J, Miliaresis C, Rodgers L, McCombie R, Bigner SH, Giovanella BC, Ittmann M, Tycko B, Hibshoosh H, Wigler MH and Parsons R: PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer. Science 275: 1943-1947, 1997. (Pubitemid 27148818)
16. Steck PA, Pershouse MA, Jasser SA, Yung WK, Lin H, Ligon AH, Langford LA, Baumgard ML, Hattier T, Davis T, Frye C, Hu R, Swedlund B, Teng DH and Tavtigian SV: Identification of a candidate tumour suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers. Nat Genet 15: 356-362, 1997. (Pubitemid 27147102)
17. Maehama T and Dixon JE: The tumor suppressor, PTEN/MMAC1, dephosphorylates the lipid second messenger, phosphatidylinositol 3,4,5-trisphosphate. J Biol Chem 273: 13375-13378, 1998. (Pubitemid 28268370)
18. Wu X, Senechal K, Neshat MS, Whang YE and Sawyers CL: The PTEN/MMAC1 tumor suppressor phosphatase functions as a negative regulator of the phosphoinositide 3-kinase/Akt pathway. Proc Natl Acad Sci USA 95: 15587-15591, 1998. (Pubitemid 29018743)
19. Rasheed BK, Stenzel TT, McLendon RE, Parsons R, Friedman AH, Friedman HS, Bigner DD and Bigner SH: PTEN gene mutations are seen in high-grade but not in low-grade gliomas. Cancer Res 57: 4187-4190, 1997. (Pubitemid 27413420)
20. Guldberg P, thor Straten P, Birck A, Ahrenkiel V, Kirkin AF and Zeuthen J: Disruption of the MMAC1/PTEN gene by deletion or mutation is a frequent event in malignant melanoma. Cancer Res 57: 3660-3663, 1997. (Pubitemid 27381203)
21. Gray IC, Phillips SM, Lee SJ, Neoptolemos JP, Weissenbach J and Spurr NK: Loss of the chromosomal region 10q23-25 in prostate cancer. Cancer Res 55: 4800-4803, 1995.
22. Suzuki H, Freije D, Nusskern DR, Okami K, Cairns P, Sidransky D, Isaacs WB and Bova GS: Interfocal heterogeneity of PTEN/MMAC1 gene alterations in multiple metastatic prostate cancer tissues. Cancer Res 58: 204-209, 1998. (Pubitemid 28047054)
23. Kong D, Suzuki A, Zou TT, Sakurada A, Kemp LW, Wakatsuki S, Yokoyama T, Yamakawa H, Furukawa T, Sato M, Ohuchi N, Sato S, Yin J, Wang S, Abraham JM, Souza RF, Smolinski KN, Meltzer SJ and Horii A: PTEN1 is frequently mutated in primary endometrial carcinomas. Nat Genet 17:143-144, 1997.
24. Risinger JI, Hayes K, Berchuck A and Barrett JC: PTEN/MMAC1 Mutations in endometrial cancers. Cancer Res 57: 4736-4738, 1997. (Pubitemid 27468978)
25. Tashiro H, Blazes MS, Wu R, Cho KR, Bose S, Wang SI, Li J, Parsons R and Ellenson LH: Mutations in PTEN are frequent in endometrial carcinoma but rare in other common gynecological malignancies. Cancer Res 57: 3935-3940, 1997. (Pubitemid 27427679)
26. Rhei E, Kang L, Bogomolniy F, Federici MG, Borgen PI and Boyd J: Mutation analysis of the putative tumor suppressor gene PTEN/MMAC1 in primary breast carcinomas. Cancer Res 57: 3657-3659, 1997. (Pubitemid 27381202)
27. Zhang L, Liu T, Liu H, Gao J and Gu C: Loss and inactivation of PTEN/MMAC1/TEP1 gene in lung cancer. Zhonghua Bing Li Xue Za Zhi 29: 85-88, 2000.
28. Piao Z, Park C, Park JH and Kim H: Allelotype analysis of hepatocellular carcinoma. Int J Cancer 75: 29-33, 1998. (Pubitemid 28113973)
29. Fujiwara Y, Hoon DS, Yamada T, Umeshita K, Gotoh M, Sakon M, Nishisho I and Monden M: PTEN/MMAC1 mutation and frequent loss of heterozygosity identified in chromosome 10q in a subset of hepatocellular carcinomas. Jpn J Cancer Res 91: 287-292, 2000. (Pubitemid 30198168)
30. Guo SP, Wang L, Wang WL, Li QL, Wang WY and Zhang J: Mutations of tumor suppressor gene PTEN mutations in hepatocellular carcinoma and its implications in tumor proliferation and apoptosis. Zhonghua Bing Li Xue Za Zhi 35: 467-472, 2006. (Pubitemid 44596130)
31. Kawamura N, Nagai H, Bando K, Koyama M, Matsumoto S, Tajiri T, Onda M, Fujimoto J, Ueki T, Konishi N, Shiba T and Emi M: PTEN/MMAC1 mutations in hepatocellular carcinomas: somatic inactivation of both alleles in tumors. Jpn J Cancer Res 90: 413-418, 1999. (Pubitemid 29213546)
32. Yao YJ, Ping XL, Zhang H, Chen FF, Lee PK, Ahsan H, Chen CJ, Lee PH, Peacocke M, Santella RM and Tsou HC: PTEN/MMAC1 mutations in hepatocellular carcinomas. Oncogene 18: 3181-3185, 1999. (Pubitemid 29261240)
33. Yeh KT, Chang JG, Chen YJ, Chen ST, Yu SY, Shih MC, Perng LI, Wang JC, Tsai M and Chang CP: Mutation analysis of the putative tumor suppressor gene PTEN/MMAC1 in hepatocellular carcinoma. Cancer Invest 18: 123-129, 2000. (Pubitemid 30118405)
34. Zhang LN, Zha XL, Yu Q and He JY: Mutation analysis of the tumor suppressor gene PTEN/MMAC1/TEP1 in human hepatocellular carcinoma. Shi Yan Sheng Wu Xue Bao 33: 223-227, 2000.
35. Horie Y, Suzuki A, Kataoka E, Sasaki T, Hamada K, Sasaki J, Mizuno K, Hasegawa G, Kishimoto H, Iizuka M, Naito M, Enomoto K, Watanabe S, Mak TW and Nakano T: Hepatocyte-specific Pten deficiency results in steatohepatitis and hepatocellular carcinomas. J Clin Invest 113: 1774-1783, 2004. (Pubitemid 39071669)
36. Stiles B, Wang Y, Stahl A, Bassilian S, Lee WP, Kim YJ, Sherwin R, Devaskar S, Lesche R, Magnuson MA and Wu H: Liver-specific deletion of negative regulator Pten results in fatty liver and insulin hypersensitivity. Proc Natl Acad Sci USA 101: 2082-2087, 2004. (Pubitemid 38229018)
37. Bonneau D and Longy M: Mutations of the human PTEN gene. Hum Mutat 16: 109-122, 2000. (Pubitemid 30604900)
38. Fan X, Aalto Y, Sanko SG, Knuutila S, Klatzmann D and Castresana JS: Genetic profile, PTEN mutation and therapeutic role of PTEN in glioblastomas. Int J Oncol 21: 1141-1150, 2002.
39. Simpkins SB, Peiffer-Schneider S, Mutch DG, Gersell D and Goodfellow PJ: PTEN mutations in endometrial cancers with 10q LOH: additional evidence for the involvement of multiple tumor suppressors. Gynecol Oncol 71: 391-395, 1998. (Pubitemid 29022325)
40. Cook WD and McCaw BJ: Accommodating haploinsufficient tumor suppressor genes in Knudson's model. Oncogene 19: 3434-3438, 2000. (Pubitemid 30479338)
41. Podsypanina K, Ellenson LH, Nemes A, Gu J, Tamura M, Yamada KM, Cordon-Cardo C, Catoretti G, Fisher PE and Parsons R: Mutation of Pten/Mmac1 in mice causes neoplasia in multiple organ systems. Proc Natl Acad Sci USA 96: 1563-1568, 1999. (Pubitemid 29098491)
42. Leslie NR and Downes CP: PTEN function: how normal cells control it and tumour cells lose it. Biochem J 382: 1-11, 2004. (Pubitemid 39141560)